Improvement of Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus under Insulin Treatment by Reimbursement for Self-Monitoring of Blood Glucose-Reference-Cited by-同舟云学术

Improvement of Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus under Insulin Treatment by Reimbursement for Self-Monitoring of Blood Glucose

Published:2018 Issue:1 Volume:42 Page:28
ISSN:2233-6079
Container-title:Diabetes & Metabolism Journal
language:en
Short-container-title:Diabetes Metab J

Author:

Song Young Shin¹,Koo Bo Kyung¹²³,Kim Sang Wan¹²,Yi Ka Hee¹²,Shin Kichul²³,Moon Min Kyong¹²^ORCID

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

2. Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.

3. Center for Medical Informatics, Seoul Metropolitan Government Boramae Medical Center, Seoul, Korea.

Funder

Creative Industrial Technology Development Program

Korea Meteorological Administration

Publisher

Korean Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.4093/dmj.2018.42.1.28

Reference25 articles.

1. Structured Self-Monitoring of Blood Glucose Significantly Reduces A1C Levels in Poorly Controlled, Noninsulin-Treated Type 2 Diabetes

2. The Impact of Blood Glucose Self-Monitoring on Metabolic Control and Quality of Life in Type 2 Diabetic Patients

3. Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants

4. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The application of multivariate adaptive regression splines in exploring the influencing factors and predicting the prevalence of HbA1c improvement;Annals of Palliative Medicine;2021-02

2. Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2021-01

3. Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study;Journal of Diabetes Research;2019-12-31

4. Self-Monitoring of Blood Glucose in Patients with Insulin-Treated Type 2 Diabetes Mellitus;Diabetes & Metabolism Journal;2018